Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Open the books on private 9315 4466 Quebec Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(113)
•••
Comment by JohnnyRingo20on Nov 17, 2022 9:52am
80 Views
Post# 35106437

RE:Open the books on private 9315 4466 Quebec Inc.

RE:Open the books on private 9315 4466 Quebec Inc.
SamV21 wrote: We will find the Tetra money trail with kick backs on deals made by Guy (president) and paid to his wife(vise president ) and himself , why connect with all these companys and make all these deals when you have nothing to sell , no product , non in the foreseeable future ? It was all about making investors believe that those connections for product were needed , he bought Panag Pharma and they will take Tetra over when the doors are closed , shareholders will never see a penny from Guy or Tetra and his private Inc numbered company .Company is only worth 6.5 million now and if Tetra goes bankrupt 10,000,000 is payable to Panag Pharma. It was always about Guy and his success never the shareholders or being accountable to them. Scammer ! Now the big boys are propping the stock up with a big buy at .015 hoping they can squeeze .02 out of Guys fake pumping company , he fooled a  lot of people , he will pay one day  for stealing millions from the wrong people ! 


unfortunately I doubt he will pay. Lots of these scam companies out there. Look at Huge/FSD with the Kraft building, Kalytera etc etc. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities